On September 26, 2017, the Board of Directors of Argos Therapeutics, Inc. elected Richard G. Morrison, Ph.D., effective immediately, as a Class III director of the company, with a term expiring at the company's 2020 Annual Meeting of stockholders, to fill a vacancy on the Board. Dr. Morrison spent the majority of his career at Eli Lilly and Company where he served for thirty years in a variety of international leadership roles, including most recently as president and general manager of Lilly's operations in Latin America.